Table 2.
Comparison of the availability of the DM and CVD medicines between the public hospitals, private hospitals and pharmacies
| Availability of the medicines in % | ||||
|---|---|---|---|---|
| Medicines | Private hospitals (n = 23) | Public hospitals (n = 22) | Private pharmacy (n = 100) | P value |
| A: Medicines with a statistically significant difference between study sites | ||||
| ARBs | 87.0 | 31.8 | 99.0 | <0.001 |
| ARB-thiazide diuretics | 78.3 | 27.3 | 96.0 | <0.001 |
| Statins | 87.0 | 18.2 | 98.0 | <0.001 |
| Warfarin | 65.2 | 18.2 | 74.8 | <0.001 |
| Soluble insulin | 100 | 81.8 | 58.6 | <0.001 |
| Thiazide diuretics | 82.6 | 95.5 | 97.0 | 0.025 |
| Spironolactone | 91.3 | 68.2 | 90.9 | 0.012 |
| LMWH | 47.8 | 9.1 | 33.3 | 0.018 |
| UFH | 39.1 | 4.6 | 19.2 | 0.014 |
| Isosorbide mono nitrate | 30.4 | 4.6 | 32.3 | 0.030 |
| B: Medicines with no statistically significant difference between study sites | ||||
| Captopril | 91.3 | 95.5 | 98.0 | 0.277 |
| CCB | 95.7 | 100 | 100 | 0.071 |
| Beta blockers | 95.6 | 100 | 97.0 | 0.650 |
| Anti platelet drugs | 91.3 | 91.0 | 97.0 | 0.317 |
| Digoxin | 91.3 | 81.2 | 82.3 | 0.579 |
| Pre mixed insulin | 69.6 | 77.3 | 54.1 | 0.080 |
| Intermediate insulin | 43.5 | 27.3 | 34.3 | 0.516 |
| Benzathine penicillin | 91.3 | 100 | 83.8 | 0.097 |
| Loop duiretics | 91.3 | 100 | 86.9 | 0.182 |
| Hydralazine | 65.2 | 45.6 | 43.4 | 0.166 |
| OHA | 100 | 100 | 100 | 1 |
UFH Unfractionated heparin, LMWH Low molecular weight heparin, ARB Angiotensin II receptor blockers, ACEI Angiotensin converting enzyme inhibitors, CCB Calcium channel blockers, OHA Oral hypoglycaemic agents